India to Begin Clinical Trial for 4 Ayurvedic Drugs
The Government of India is working on four ayurvedic medicine formulations to treat COVID-19, said AYUSH Minister on Thursday, adding that trials are likely to begin within a week.
Union Minister of State for AYUSH Shripad Y Naik, in a tweet, said, "The @moayush & the @CSIR_IND are working together on validating four Ayush formulations against #COVID19Pandemic and the trials will start within one week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients."
The doctors have yet not found any concrete solution in the traditional medicine system of Ayurveda or in any other allopathic drug across the world. Even though plasma therapy is being resorted to for helping COVID-19 patients recover from the deadly virus in India, the treatment has not been proven as totally effective.
The US Food and Drug Administration has given its nod to Gilead's antiviral drug remdesivir in May for emergency use on COVID-19 patients.